Status:
UNKNOWN
Dual-scopic Pancreatic Necrosectomy (DPN)
Lead Sponsor:
First People's Hospital of Hangzhou
Conditions:
Pancreatitis
Pancreatitis, Acute Necrotizing
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The LPN procedure is performed under general anesthesia. The transperitoneal access to peripancreatic space is via the gastro-colic ligament and greater omentum, effusion and pus is removed by laparos...
Eligibility Criteria
Inclusion
- All patients ages 18 or above admitted to UPMC with a diagnosis of AP based on at least 2 of the following criteria:(i) abdominal pain characteristic of AP (ii) serum amylase and/or lipase ≥ 3 times the upper limit of normal (iii) characteristic findings of AP on abdominal CT scan will be screened for study enrollment.
Exclusion
- Less than 18 years of age
- Pregnant women
- Presence of renal dysfunction (Cr\>1.5mg/dL)
- Pre existing heart dysfunction or NYHA classification score above III
- Coagulation disorder
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04443595
Start Date
July 1 2020
End Date
December 31 2025
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China, 310006